FONAR Corporation (FONR)

$17.66

-0.10 (-0.56%)
Rating:
Recommendation:
Buy
Symbol FONR
Price $17.66
Beta 0.910
Volume Avg. 0.01M
Market Cap 115.464M
Shares () -
52 Week Range 13.28-19.0
1y Target Est -
DCF Unlevered FONR DCF ->
DCF Levered FONR LDCF ->
ROE 2.92% Neutral
ROA 2.20% Neutral
Operating Margin -
Debt / Equity 32.35% Neutral
P/E 11.47 Strong Buy
P/B 0.76 Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest FONR news


Mr. Timothy R. Damadian M.D.
Healthcare
Medical Devices
NASDAQ Capital Market

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates through two segments, Medical Equipment segment, and Physician Management and Diagnostic services segment. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters and the development and implementation of practice growth and marketing strategies. The company owns and operates 5 diagnostic imaging facilities in Florida; and manages 39 MRI scanning facilities, including 25 facilities located in New York and 14 situated in Florida. It markets its scanners to private diagnostic imaging centers and hospitals. The company was incorporated in 1978 and is based in Melville, New York.